๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma

โœ Scribed by Osamu Noguchi; Nobuyuki Enomoto; Takaaki Ikeda; Fumie Kobayashi; Fumiaki Marumo; Chifumi Sato

Book ID
118567269
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
781 KB
Volume
24
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Expression of hepatocyte growth factor a
Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma
โœ T Ueki; J Fujimoto; T Suzuki; H Yamamoto; E Okamoto ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 240 KB

The c-met proto-oncogene encodes the tyrosine kinase receptor for hepatocyte growth factor (HGF), a potent mitogen and motogen for epithelial cells. Because of its profound effects on cell growth and motility, HGF may be important in the development of cancer metastases in hepatocellular carcinoma (

Expression of hepatocyte growth factor a
Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma
โœ T Ueki; J Fujimoto; T Suzuki; H Yamamoto; E Okamoto ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 237 KB

mal and malignant epithelial cells and several other cell The c-met proto-oncogene encodes the tyrosine kinase types, including endothelial cells and melanocytes. 4,5 receptor for hepatocyte growth factor (HGF), a potent It has been reported that the expression of c-Met is enmitogen and motogen for

Tumor angiogenesis, hepatocyte growth fa
Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma
โœ Satoshige Wagatsuma; Ryo Konno; Shinji Sato; Akira Yajima ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 310 KB ๐Ÿ‘ 1 views

## Background: This study was designed to evaluate the significance of tumor angiogenesis and angiogenic factors such as hepatocyte growth factor (hgf) and c-met in determining the prognoses of 93 patients with endometrial carcinoma. ## Methods: By immunohistochemical staining, this retrospective